Legis Daily

Gabriella Miller Kids First Research Act 2.0

USA116th CongressHR-6556| House 
| Updated: 4/17/2020
Jennifer Wexton

Jennifer Wexton

Democratic Representative

Virginia

Cosponsors (46)
Doug LaMalfa (Republican)Dwight Evans (Democratic)Tom O'Halleran (Democratic)Tom Cole (Republican)Markwayne Mullin (Republican)Marc A. Veasey (Democratic)Pete Olson (Republican)Robin L. Kelly (Democratic)Abigail Davis Spanberger (Democratic)Lisa Blunt Rochester (Democratic)Jackie Speier (Democratic)Darren Soto (Democratic)Sheila Jackson Lee (Democratic)Robert J. Wittman (Republican)J. Luis Correa (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)David B. McKinley (Republican)Gus M. Bilirakis (Republican)H. Morgan Griffith (Republican)Bill Flores (Republican)G. K. Butterfield (Democratic)Elaine G. Luria (Democratic)Ann Wagner (Republican)Doris O. Matsui (Democratic)Denver Riggleman (Republican)Glenn Grothman (Republican)Josh Harder (Democratic)Mark Takano (Democratic)Mary Gay Scanlon (Democratic)Michael T. McCaul (Republican)Ted S. Yoho (Republican)Michael F. Q. San Nicolas (Democratic)Jerry McNerney (Democratic)Peter Welch (Democratic)TJ Cox (Democratic)Susan W. Brooks (Republican)Nanette Diaz Barragán (Democratic)Cathy McMorris Rodgers (Republican)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Gerald E. Connolly (Democratic)Katie Porter (Democratic)Mike Levin (Democratic)

Financial Services Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Gabriella Miller Kids First Research Act 2.0 This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2020
Introduced in House
Apr 17, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 17, 2020
Sponsor introductory remarks on measure. (CR E373)
  • April 17, 2020
    Introduced in House


  • April 17, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 17, 2020
    Sponsor introductory remarks on measure. (CR E373)

Health

Banking and financial institutions regulationChild healthCivil actions and liabilityGovernment trust fundsHealth programs administration and fundingMedical researchResearch administration and fundingSecurities and Exchange Commission (SEC)

Gabriella Miller Kids First Research Act 2.0

USA116th CongressHR-6556| House 
| Updated: 4/17/2020
Gabriella Miller Kids First Research Act 2.0 This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2020
Introduced in House
Apr 17, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 17, 2020
Sponsor introductory remarks on measure. (CR E373)
  • April 17, 2020
    Introduced in House


  • April 17, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 17, 2020
    Sponsor introductory remarks on measure. (CR E373)
Jennifer Wexton

Jennifer Wexton

Democratic Representative

Virginia

Cosponsors (46)
Doug LaMalfa (Republican)Dwight Evans (Democratic)Tom O'Halleran (Democratic)Tom Cole (Republican)Markwayne Mullin (Republican)Marc A. Veasey (Democratic)Pete Olson (Republican)Robin L. Kelly (Democratic)Abigail Davis Spanberger (Democratic)Lisa Blunt Rochester (Democratic)Jackie Speier (Democratic)Darren Soto (Democratic)Sheila Jackson Lee (Democratic)Robert J. Wittman (Republican)J. Luis Correa (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)David B. McKinley (Republican)Gus M. Bilirakis (Republican)H. Morgan Griffith (Republican)Bill Flores (Republican)G. K. Butterfield (Democratic)Elaine G. Luria (Democratic)Ann Wagner (Republican)Doris O. Matsui (Democratic)Denver Riggleman (Republican)Glenn Grothman (Republican)Josh Harder (Democratic)Mark Takano (Democratic)Mary Gay Scanlon (Democratic)Michael T. McCaul (Republican)Ted S. Yoho (Republican)Michael F. Q. San Nicolas (Democratic)Jerry McNerney (Democratic)Peter Welch (Democratic)TJ Cox (Democratic)Susan W. Brooks (Republican)Nanette Diaz Barragán (Democratic)Cathy McMorris Rodgers (Republican)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Gerald E. Connolly (Democratic)Katie Porter (Democratic)Mike Levin (Democratic)

Financial Services Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Banking and financial institutions regulationChild healthCivil actions and liabilityGovernment trust fundsHealth programs administration and fundingMedical researchResearch administration and fundingSecurities and Exchange Commission (SEC)